Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
cannabidiol
Pharma
Jazz must hash new plan for cannabis drug after MS trial failure
Jazz said that its nabiximols oromucosal spray has flunked a phase 3 trial, coming up short in helping multiple sclerosis patients with spasticity.
Kevin Dunleavy
Jun 28, 2022 10:35am
RLS bags $10M to trial dry powder inhaled CBD in anxiety
Apr 12, 2022 8:00am
GW plots path to new drug approvals as Epidiolex coasts
Nov 5, 2020 11:14am
GW Pharma takes docs on virtual trip to marijuana greenhouse
Jun 18, 2019 4:42pm
Cannabinoid hopeful FSD taps rival’s veteran executive as CEO
Nov 26, 2018 10:43am
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
Oct 5, 2018 11:24pm